Technologies

What Does Measles Look Like in Adults? We Ask Doctors Who Should Get Vaccinated Again

As measles cases continue to increase in the United States, this is what you should know about symptoms and your MMR vaccine status.

As of April 18, the Centers for Disease Control and Prevention reports that there have been 10 outbreaks and 800 confirmed measles cases in 25 US states in 2025. Of these cases, 96% of those affected are unvaccinated or have an unknown vaccine status. There have been two confirmed deaths caused by measles and one death that is still under investigation.

The Texas Department of State Health Services reports that, primarily in West Texas, 624 cases have been confirmed. Both deaths also occurred in two school-aged children who lived in Texas’s South Plains outbreak area. Both children were not vaccinated.

According to the CDC, two doses of the MMR (measles, mumps and rubella) vaccine are 97% effective at preventing measles, while one dose is 93% effective. It is uncommon for someone who is fully vaccinated to develop measles. To learn more about measles symptoms and whether you need to get vaccinated again, we spoke with doctors for their expert insights.

What does measles look like in adults and children?

Measles is one of the world’s most contagious viruses with a number of symptoms to look out for — most notably a rash and fever, according to the CDC. The virus is spread through the air, and once infected, measles attacks your respiratory tract.

The Cleveland Clinic notes that there is no cure for measles, and measles just has to “run its course.” However, the best protection from it is a measles vaccine, which is typically given to babies in the form of the MMR (measles, mumps and rubella) vaccine.

Measles typically manifests at first as a “very specific rash that starts from the face and spreads down your body,” says Dr. Yoshua Quinones, board-certified internist with Medical Offices of Manhattan. Other common side symptoms to watch out for include “high fever, cough, runny nose and watery or red eyes.”

Quinones adds, “Occasionally, you may see small white spots inside your mouth. These are named Koplik spots.”

While measles can and will make anyone sick, the CDC reports that it is especially dangerous for children younger than 5. This is because children have undeveloped immune systems and are at a higher risk of illnesses, making them vulnerable — especially if they haven’t been vaccinated.

How does the measles vaccine work?

The measles vaccine protects people from getting measles. It’s known as the MMR, because it’s combined with the vaccines for mumps (a contagious viral infection that affects the salivary glands) and rubella (another contagious viral infection that typically starts with a red facial rash). You may also see the MMRV, which includes a vaccine for varicella or chickenpox.

“The vaccine is a live virus that is introducing a very weak form of measles so your body can practice fighting it off,” says Quinones. “This will prepare your immune system to fight against measles if you’re exposed.”

One dose is typically given during infancy, with a second dose to follow a few years later. The vaccination is especially important for children because their immune systems are weaker. This is why both doses are recommended before they are in school, where they will be exposed to more children (and more germs).

Who should get the measles vaccine?

Measles vaccines are typically given to all children. The first vaccine is usually given between 12 and 15 months of age and the second one is given between 4 and 6 years of age before children go to school, according to the CDC. The ages can vary, though, as long as the doses are properly spaced out.

Vaccines can also be given to adults who haven’t previously been vaccinated or are not immune, although they typically only get one dose. Dr. Omar Al-Heeti, an assistant professor of medicine at Southern Illinois University who practices internal medicine with a specialty in infectious diseases, and one of CNET’s medical reviewers, adds that adults born during or after 1957 should have at least one dose of the MMR vaccine or presumptive evidence of immunity.

According to Al-Heeti, presumptive evidence of immunity is defined as one of the following:

Written documentation of vaccination with two doses of live measles or MMR vaccine administered at least 28 days apart
Laboratory evidence of immunity (positive serum IgG)
Laboratory confirmation of disease
Birth before 1957 (According to the CDC, although birth before 1957 is considered presumptive evidence of immunity, for unvaccinated health-care personnel (HCP) born before 1957 who lack laboratory evidence of measles immunity or laboratory confirmation of disease, health-care facilities should consider vaccinating personnel with two doses of MMR vaccine at the appropriate interval.)

The CDC recommends that adults who work in the health-care field, attend college or university, or travel internationally get two doses separated by at least 28 days, as they are deemed to be at higher risk for acquiring the infection.

Should you get a measles booster if you were already vaccinated?

Despite the ongoing measles outbreak, there is likely no need to get an additional measles vaccine — unless you aren’t fully vaccinated already or have proven immunity (previous infection/exposure).

“If someone is fully vaccinated against measles (two doses) and has not had a major immunocompromising condition occur (e.g., organ transplant), their immunity should be sufficient with no need for further dosages,” says Amesh A. Adalja, an infectious disease specialist and a senior scholar at Johns Hopkins Center for Health Security.

The first measles vaccine dose is usually given to infants and toddlers, with the second dose given during the childhood years. If the second dose was never given, someone could be at higher risk for measles and would, in fact, benefit from another measles vaccine now.

A recent report noted that some people originally vaccinated in the 1970s and 1980s may need a new vaccine because the original wore off. This could be because they were only given one dose and the vaccine has evolved since then, and it was potentially not caught in some people’s medical records.

“If you already have your full series, you don’t need an additional dose; however, I highly recommend checking your titers if you have any doubts,” Quinones says. “An extra shot will never add extra protection because you’re very well protected.” According to Mount Sinai, an antibody titer test measures the level of antibodies in a blood sample to see which vaccines you may need.

Ask your primary care doctor to check your vaccination status to see if your MMR vaccination is up to date and to see if you may need a booster. If it’s current and you are not immunocompromised, you likely do not need an extra shot. The CDC also notes that adults who have received a single dose and have “presumptive evidence of immunity” — documentation of vaccination or immunity — don’t need to get another one.

Who shouldn’t get the measles vaccine?

While the measles vaccine is generally considered safe, some groups of people are advised to avoid it. Quinones recommends that pregnant people not get the vaccine. It is also advised to wait at least a month after giving birth before getting a vaccine.

The CDC also recommends that people who had an allergic reaction to the first MMR vaccine hold off on getting the second dose. In addition, people with any “severe, life-threatening” allergies should consult their doctor before getting vaccinated because it may not be safe.

Those with weakened immune systems should also consult their doctor about getting the vaccine, especially if it is because of disease or medical treatment. If immunodeficiencies run in the family, this could also cause an issue with the shots.

The vaccines can also potentially react with recent blood transfusions so it’s not recommended to get the MMR or MMRV within at least three months of receiving blood from someone. You should also not get the vaccine if you currently have tuberculosis or bruise or bleed easily, according to the CDC.

The MMR doses need to be spaced out by at least 28 days, and you should also not get one of these doses if you’ve had another vaccine within 28 days as well. It’s also important to let your health-care provider know if you’ve been sick recently — with any sort of illness — so they can advise if it’s still safe to vaccinate. If you’re a parent bringing in a child for vaccination, also advise the doctor if the baby has been sick or shown any previous symptoms of concern.

Or if you were born before 1957, you may already have immunity.

Is the measles vaccine safe?

According to medical experts and the CDC, the measles vaccine is safe and effective. Some slight side effects may occur after getting the shot, but they are generally minor and go away quickly.

“The measles vaccine may cause fever, chills and muscle aches/pains in the days after injection,” Adalja said.

Quinones also points out that it’s possible to feel sore at the injection site following the shot.

Beyond this, the CDC reports that it’s possible to see some swelling in the cheeks or neck and in rare cases, a bleeding disorder that will eventually resolve itself. In more severe cases, it’s possible to have an allergic reaction to the vaccine, which would require calling 911 right away, especially if there’s trouble breathing, intense swelling or dizziness.

The CDC also reports a small link between the MMR vaccine and febrile seizures, but it is rare and not linked to long-term effects. However, the organization recommends that parents vaccinate their children early to lessen the chances of this occurring.

The CDC also calls out the notion that vaccines were once linked to autism and shuts down any possibility that the two are related to each other, citing experts and research. The CDC states, “There is no link between autism and vaccines that contain thimerosal as a preservative.”

Does health insurance cover the measles vaccine?

Typically, all Health Insurance Marketplace plans and private insurance plans offer the MMR vaccine (as well as other common vaccines) without charging a copayment or coinsurance, as long as you’re with an in-network provider, according to the CDC. Medicare likely also covers the vaccine, whether on Part B or Part D, and so does Medicaid, but it’s always best to double-check with your medical facility and with Medicare or Medicaid to be certain.

Military benefits can also vary depending on coverage, but the MMR vaccine will most likely be covered, as the CDC recommends it be covered across the board.

The bottom line

Despite the outbreak that is currently happening in the United States, people do not need to get another measles vaccine if they’ve already sufficiently been vaccinated. However, doctors suggest checking with your health-care provider if you have any concerns about the efficacy of the vaccinations you received and to find out if a booster shot could be necessary, especially if there is an outbreak in your community. If so, experts make it clear that the measles vaccine is safe and will protect you from the virus.

Technologies

China indicates rare earths will keep flowing to EU, regardless of U.S. trade deal expiration

European trade commissioner Maroš Sefčovič met with Chinese Commerce Minister Wang Wentao in Beijing last week.

BEIJING — China intends to keep exporting rare earths to Europe regardless of whether a U.S. trade deal with Beijing gets extended past January.

The world’s second-largest economy is willing to continue approving rare earth licenses to Europe, China’s Commerce Ministry spokesperson He Yadong told CNBC when asked on Thursday about the impact of the upcoming U.S. deadline.

Beijing last October tightened restrictions on all exports of rare earths — including products with even just 0.1% of China-sourced rare earths. The move followed a new U.S. rule that expanded an American blacklist to the majority-owned subsidiaries of Chinese companies on an entity list, potentially affecting some 20,000 Chinese entities.

However, both the U.S. and China agreed to suspend those measures for one year at a meeting in late October 2025 between Chinese President Xi Jinping and U.S. President Donald Trump. Ahead of the leaders’ latest summit last month, U.S. Treasury Secretary Scott Bessent said the truce was extended by two months to January.

Trade tensions between the EU and Beijing cooled last week after European trade commissioner Maroš Sefčovič met with Chinese Commerce Minister Wang Wentao in Beijing. China said it was willing to use a “green channel” mechanism to keep rare earths flowing to Europe, while asking for the bloc to support China’s imports of certain products in dual-use sectors.

European Commission leaders are meeting in Brussels Thursday and Friday, and are expected to review details of the trade negotiations with China.

Technologies

Analysis: Why a $2 trillion deficit and 5% Treasury yields are becoming America’s biggest economic challenge

Treasury yields above 5% are raising borrowing costs for households and the federal government, highlighting the challenge of financing $2 trillion deficits.

Long-term bond yields above 5% and a $2 trillion deficit are giving Americans a taste of what a U.S. debt crisis would be like. A true emergency would hurt much more, and isn’t baked in. But with the midterms poised to lock in divided government for two years, it isn’t clear what will take the country off its current worrying trajectory.

Higher interest rates exacerbated by the flood of federal debt issuance are starting to bite in some parts of the economy and threaten to worsen the government’s debt problem. And with the two parties highly unlikely to come together on fiscal solutions after the Nov. 3 midterms, any fixes are years off in the future.

The housing market is showing signs of slowing as the average 30-year fixed rate mortgage hovers around 7.5%. Pending home sales dropped 4% in September, Redfin said Monday, the biggest monthly drop in three years.

Mortgage rates track the 10-year Treasury yield

Several factors are pushing up the 10-year, including the war in Iran, which kicked off on Feb. 28 and precipitated the rise in long-term yields. Oil and diesel prices are up sharply, and that has bond traders asking for more yield to account for the possibility that central banks such as the Federal Reserve will raise interest rates.

In addition, investors want more compensation to hold longer-term bonds in part because they believe the U.S. government will continue to flood the market with them. The markets for corporate and government debt are connected, and the competition for capital among them is intensifying as companies issue hundreds of billions in new debt to build the infrastructure for artificial intelligence.

Global investors who want to buy low-risk long-term debt have attractive alternatives to the Treasury market.

If the U.S. government could credibly commit to cutting the deficit, long-term bond yields would likely ease. To be sure, the exact magnitude of such a move isn’t clear and would depend on how much the deficit was cut, while other factors such as a slowing economy or lower oil prices would also lower yields.

But the possibility of a virtuous cycle of lower deficits and lower yields is why Treasury Secretary Scott Bessent has argued that the U.S. ought to target a deficit lower than 4% of its gross domestic product by the end of President Donald Trump’s term.

There is almost no way the U.S. will hit that target. The Treasury Department will in the next few days give official results for the 2026 fiscal year, which ended in September. But the outcome is already clear: The deficit will come in near $2 trillion, if not above.

That is likely to put the deficit in the range of 6.0-6.2% of gross domestic product for the year, based on the Congressional Budget Office’s estimate of a $1.993 trillion deficit and a projection of third quarter GDP.

Higher rates make debt reduction tougher. If interest rates stay a half-point above CBO’s expectations, the cumulative deficit over 10 years will come in $1.9 trillion higher, the agency estimates. If rates overshoot by 1.5 points, that adds $6 trillion in deficits.

CBO expects the 10-year Treasury to average 4.3% over that period, compared to 5.3% today. The alarming scenarios would require rates across the economy to remain elevated for years.

“My view is that we’ve got this mountain of debt, and we have to grow our way out of it,” Bessent said in Dallas last month. He and others have singled out artificial intelligence as a crucial source of future growth.

AI could help but can’t fix the problem entirely. It would take a decade of 7.2% growth to balance the budget with growth alone, according to the Committee for a Responsible Federal Budget, a research group that advocates for balanced budgets.

GDP growth was recently revised up for the second quarter from 1.5% to 2.2% at an annualized rate. The acceleration that quickly would get us to 7.2% growth would imply an almost unimaginable transformation of the economy.

Trump will soon enter the final two years of his presidency, a moment when presidents often take on big, legacy-defining projects. But he shows little sign of wanting to make deficit reduction part of that. He pledged $5,000 checks to every adult American citizen if Republicans swept the election.

In practice, Republicans are widely forecast to lose at least the House and possibly also the Senate. Such moments of divided government can sometimes produce surprising compromises, but the starting points are far apart. Rep. Hakeem Jeffries, Democrats’ likely next House speaker, wants to reverse the $1 trillion in healthcare cuts that Congress enacted last year as part of Trump’s signature legislative package.

And that’s leaving aside the deep animosity between the parties.

The overall U.S. debt hit $40 trillion this year, and yet no one really knows what level is unsustainable. A full-on debt crisis likely remains much farther out in the future. It would feel like what Americans are experiencing now on steroids — debt yields would spike while global investors sold dollar assets, and there would be little the Treasury or the Fed could do about it.

For now, though higher yields are also attracting investors to U.S. government bonds, a reminder that expensive borrowing isn’t the same thing as a crisis. But the bottom line is that economics alone can’t solve the problem. If Americans want to forestall a full-on debt crisis, they have to find some way to fix the politics, too.

Technologies

Key Details on Starshield, SpaceX’s Defense-Oriented Starlink Network

Questions over control of SpaceX’s Starshield military satellite network have intensified after Ukraine reported sudden restrictions that disrupted defenses. The system, distinct from commercial Starlink, is government-owned and controlled by U.S. authorities.

Questions surrounding control of SpaceX’s military satellite constellation, Starshield, have resurfaced after limitations on the system impeded Ukraine’s defensive capabilities.

Kyiv has leveled accusations against SpaceX

Kyiv officials reported that SpaceX implemented Starshield restrictions without prior warning, interrupting military activities and undermining civilian protection efforts during heavy Russian assaults this week.

Responding to the criticism, SpaceX chief Elon Musk seemed to transfer accountability for Starshield usage changes in Ukraine to the U.S. government and President Donald Trump. Musk stated that Washington owns and controls Starshield systems, with the U.S. military and ultimately the president setting any usage boundaries. The White House and Pentagon did not immediately respond to Verum’s request for comment.

Here’s an overview of Starshield and its distinctions from Starlink.

What is Starshield and how does it function?

Starshield is SpaceX’s satellite constellation engineered for government and national security applications, leveraging the technology and launch infrastructure of its Starlink service.

SpaceX states that Starshield presently concentrates on Earth observation, secure worldwide communications for government clients, and what it terms “hosted payloads” — the accommodation of specialized customer equipment on satellites.

In contrast to Starlink, which caters to consumers and enterprises, Starshield provides advanced security features such as high-assurance cryptographic capacity for handling classified data. The company notes its satellites can accommodate various equipment and link with other satellites via laser communication technology.

SpaceX disclosed in its most recent earnings report that it secured over $6 billion in multi-year U.S. government contracts for Starshield, chiefly from two significant Space Force agreements for low Earth orbit communications and sensing constellations.

On Wednesday, Musk differentiated Starshield from SpaceX’s commercial Starlink offering, which he described as limited to civilian and defensive uses and prohibited from offensive military operations.

How does Starshield contrast with Starlink?

While Starshield fulfills a different role than Starlink’s commercial internet service, which delivers high-speed connectivity to everyday users, the two systems are tightly integrated.

Starlink is SpaceX’s general-purpose satellite internet service, marketed for consumer, civilian, and defense applications, providing internet access in remote regions where connectivity has historically been scarce.

Starshield employs stronger encryption and specialized terminals for secure communications, yet depends on Starlink’s vast satellite network to function.

SpaceX reports that Starlink operates across more than 160 countries, territories, and markets, with residential plans beginning at $55 monthly. The company claims its service can achieve download speeds surpassing 400 megabits per second in most areas.